i2E marks 25th year advancing Oklahoma biotech innovation

Since 1998, i2E has been a trusted partner in Oklahoma’s community and economy, walking shoulder-toshoulder with business owners and leaders to develop and strengthen their ideas, scale their companies responsibly, launch their ideas successfully, and ensure their relevance in the changing business landscape.

This year, i2E is celebrating its 25th year serving entrepreneurs and innovators, helping them to build, launch, and grow great ideas. Over the last two-and-a-half decades, i2E has seen the launch of portfolio companies working to advance medical technologies that prevent hospital acquired infections, help physicians visualize colonoscopy procedures more clearly, protect against accidental catheter disconnection, provide pain-free therapeutics that combat eye disease, reverse hearing loss, and much more.

As these new technologies draw closer to becoming available to patients worldwide, other promising discoveries continue to emerge from Oklahoma laboratories. Millions of dollars will be required to advance them to the market.

i2E works in partnership with Plains Ventures, an independent investment arm of the organization that manages both private and public funds. Plains invests in well-vetted deal flow out of i2E and from other sources in Oklahoma’s entrepreneurial ecosystem. The two organizations are integrated and work together to build Oklahoma’s future economy literally from the ground up. The success of the companies that Plains invests in creates a “virtuous cycle” that feeds back into the pipeline of deal flow support at i2E.

The following pages provide a look into some of the bioscience companies that i2E has supported over the years, all of which share a common bond – i2E was critical in ensuring these companies had the capital and expertise necessary for success.

Like the past 25 years, the future of i2E continues to be focused on fueling biotech innovation in Oklahoma and supporting the latest in groundbreaking medical technologies for the betterment of the local community and the world.

25 Years Of Impact

• Over $90 million invested in 230 companies since inception.

• Invested over $36 million in 64 startup life sciences companies.

• Provided business expertise to over 780 startup companies.

• Funded the state of Oklahoma's first "unicorn," Alkami Technologies.